Open access
2026
The Effect of Ibrutinib Therapy on Sarcopenia in Patients with Hematologic Malignancies
Aim: Sarcopenia, characterized by progressive loss of skeletal muscle mass and function, is associated with poor prognosis in patients with hematologic malignancies. Given the potential musculoskeletal effects of Bruton tyrosine kinase inhibitors, this study aimed to explore sarcopenia-related parameters in patients wi...
Öznur Aydın, Mirsad Yalçınkaya, Ayşe Kaynarçeşme et al.
· Annals of Medical Research · 0 citations